Your browser doesn't support javascript.
loading
Validation of [18F]FLT as a perfusion-independent imaging biomarker of tumour response in EGFR-mutated NSCLC patients undergoing treatment with an EGFR tyrosine kinase inhibitor.
Iqbal, R; Kramer, G M; Frings, V; Smit, E F; Hoekstra, O S; Boellaard, R.
Affiliation
  • Iqbal R; Department of Radiology & Nuclear Medicine, VU University Medical Center, PO Box 7057, 1007, MB, Amsterdam, The Netherlands. r.iqbal@vumc.nl.
  • Kramer GM; Department of Radiology & Nuclear Medicine, VU University Medical Center, PO Box 7057, 1007, MB, Amsterdam, The Netherlands.
  • Frings V; Department of Radiology & Nuclear Medicine, VU University Medical Center, PO Box 7057, 1007, MB, Amsterdam, The Netherlands.
  • Smit EF; Department of Pulmonology, VU University Medical Center, Amsterdam, The Netherlands.
  • Hoekstra OS; Department of Radiology & Nuclear Medicine, VU University Medical Center, PO Box 7057, 1007, MB, Amsterdam, The Netherlands.
  • Boellaard R; Department of Radiology & Nuclear Medicine, VU University Medical Center, PO Box 7057, 1007, MB, Amsterdam, The Netherlands.
EJNMMI Res ; 8(1): 22, 2018 Mar 27.
Article in En | MEDLINE | ID: mdl-29594931
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: EJNMMI Res Year: 2018 Document type: Article Affiliation country: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: EJNMMI Res Year: 2018 Document type: Article Affiliation country: Netherlands